跳至主要内容
临床试验/JPRN-jRCT2053190081
JPRN-jRCT2053190081进行中(未招募)1 期

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy

Miyagawa Shigeru0 个研究点目标入组 10 人开始时间: 2019年12月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Ischemic cardiomyopathy
  • 2) NYHA class III, IV
  • 3) Patients who can not expect symptomatic improvement with standard treatment for target disease. To be recognized by the third party committee with experts.
  • 4) Ejection fraction <= 35%

排除标准

  • 1) Autoimmune disease
  • 2) Allergic or hypersensitive to the immunosuppressant
  • 3) Severe infection
  • 4) Persistent shock due to worsening heart failure
  • 5) Irreversible organ failure other than heart
  • 6) Maignancy
  • 7) Pregnancy
  • 8) Alcoholic or drug addiction in recent six months
  • 9) Allergies or hypersensitivity to animals from which raw materials used
  • 10) Severe pulmonary hypertension

研究者

发起方
Miyagawa Shigeru

相似试验